USP9X has also been reported to increase the levels of β-catenin, a transcription factor linked to the growth of brain tumors [32], [33], and overexpression of USP9X has been reported to enhance the half-life and expression of β-catenin in mouse L cells and MCF7 cells, respectively [33], [34]. The gene discussed is USP9X; the disease is brain neoplasm.